Bank of New York Mellon’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76M Buy
386,939
+79,695
+26% +$858K ﹤0.01% 2357
2026
Q1
$2.6M Buy
307,244
+35,088
+13% +$384K ﹤0.01% 2679
2025
Q4
$3.07M Sell
272,156
-12,283
-4% -$152K ﹤0.01% 2604
2025
Q3
$4.27M Buy
284,439
+21,971
+8% +$320K ﹤0.01% 2414
2025
Q2
$3.7M Sell
262,468
-39,812
-13% -$710K ﹤0.01% 2438
2025
Q1
$7.27M Buy
302,280
+7,202
+2% +$254K ﹤0.01% 2018
2024
Q4
$11M Buy
295,078
+24,703
+9% +$1.15M ﹤0.01% 1880
2024
Q3
$13.5M Sell
270,375
-50,752
-16% -$1.97M ﹤0.01% 1780
2024
Q2
$11.1M Buy
321,127
+74,490
+30% +$2.95M ﹤0.01% 1902
2024
Q1
$13.5M Sell
246,637
-21,534
-8% -$1.07M ﹤0.01% 1810
2023
Q4
$11.5M Buy
268,171
+34,823
+15% +$1.08M ﹤0.01% 1910
2023
Q3
$6.07M Sell
233,348
-13
-0% -$270 ﹤0.01% 2209
2023
Q2
$5.58M Buy
233,361
+22,940
+11% +$395K ﹤0.01% 2262
2023
Q1
$2.87M Sell
210,421
-2,780
-1% -$44.2K ﹤0.01% 2594
2022
Q4
$2.96M Buy
+213,201
New +$3.01M ﹤0.01% 2634

Other funds holding BHVN

Bank of New York Mellon's BHVN Position: Q2 2026 in Review

Bank of New York Mellon increased its Biohaven (BHVN) stake by 26% in Q2 2026, buying an estimated $858K and bringing the position to 386,939 shares worth $5.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

Bank of New York Mellon first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.5M in Q3 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Bank of New York Mellon held 386,939 shares of Biohaven worth $5.76M as of Q2 2026.
  • Bank of New York Mellon bought 79,695 Biohaven shares in Q2 2026, an estimated $858K.
  • Biohaven made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2357 holding.
  • Bank of New York Mellon first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Bank of New York Mellon's Biohaven position peaked at $13.5M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.